Call Start: 08:00 January 1, 0000 9:00 AM ET
Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Q2 2021 Earnings Conference Call
August 5, 2021 08:00 ET
Company Participants
Ian Karp - Senior Vice President of Investor Relations & Corporate Communications
John Leonard - Chief Executive Officer
David Lebwohl - Chief Medical Officer
Laura Sepp-Lorenzino - Chief Scientific Officer
Glenn Goddard - Chief Financial Officer
Conference Call Participants
Maury Raycroft - Jefferies
Joon Lee - Truist Securities
Luca Issi - RBC Capital Markets
Jay Olson - Oppenheimer & Co.
Steve Seedhouse - Raymond James
Silvan Tuerkcan - JMP Securities
Jack Allen - Robert W. Baird & Co,
Yanan Zhu - Wells Fargo
Tony Butler - ROTH Capital
Operator
Good morning and welcome to the Intellia Therapeutics Second Quarter 2021 Financial Results Conference Call. My name is Jason and I will be your conference operator today. As a reminder, all participants are currently in listen-only mode. [Operator Instructions]
Following formal remarks, we will open the call up for questions. This conference is being recorded at the company's request and will be available on the company's website following the end of the call. I will now turn the conference over to Ian Karp Senior Vice President of Investor Relations and Corporate Communications at Intellia. Please, proceed.
Ian Karp
Thank you, Operator, and good morning, everyone. Welcome to Intellia's Second Quarter 2021 Earnings Call. Earlier this morning, Intellia issued a press release outlining the company's progress this quarter, as well as topics for discussion on today's call. This release can be found on the Investors and Media section of Intellia's website at intelliatx.com. This call is being broadcast live and a replay will be archived on the company's website.
At this time, I would like to take a minute to remind listeners that during the call, Intellia Management may
- Read more current NTLA analysis and news
- View all earnings call transcripts